|
1 Stenmark KR, Fagan KA, Frid MG. Hypoxia－induced pulmonary vascular remodeling cellular and molecular mechanisms. Circ Res, 2006，99(7)：675－691.
|
|
2 Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. JACC, 2004，43(12)：13s－24s.
|
|
3 Jeffery TK，Morrell NW. Molecular and cellular basis of vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis, 2002，45(3)：173－202.
|
|
4 Ehebauer M, Hayward P, Arias AM. Notch, a universal arbiter of cell fate decision. Science，2006，314(5804)：1414－1415.
|
|
5 Miele L. Notch Signaling. Clin Cancer Res, 2006，12(4)：1074－1079.
|
|
6 Li JL, Harris AL. Notch signaling from tumor cells: A new mechanism of angiogenesis. Cancer Cell, 2005，8(1)：1－3.
|
|
7 Iso T, hamamori Y, Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol，2003，23(4)：543－553.
|
|
8 Okada K, Tanaka Y, Bernstein M, et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol, 1997, 151(4)：1019－1025.
|
|
9 Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation，2004，109(2)：159－165.
|
|
10 Doi H, Iso T, Sato H, et al. Jagged1－selective Notch signaling induces smooth musle differentiation via a RBP－Jκ－dependent pathway. J Biol Chem，2006，281(39)：28555－28564.
|
|
11 Michela N, YangXin F, Kyle N, et al. Smooth muscle alpha－actin－actin is a direct target of Notch/CSL. Circ Res，2006，98(12)：1468－1470.
|
|
12 Sakata Y, Xiang F, Chen Z, et al. Transcription Factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler Thromb Vasc Biol，2004，24(11)：2069－2074.
|
|
13 Doi H, Iso T, Yamazaki M, et al. HERP1 inhibits myocardin－induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler Thromb Vasc Biol ，2005，25(11)：2328－2334.
|
|
14 Lindner V, Booth C, Prudovsky I, et al. Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell－cell interaction. Am J Pathol，2001，159：875－883.
|
|
15 Liu ZJ, Shirakawa T, Li Y, et al. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: Implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol，2003，23(1)：14－25.
|
|
16 Itoh F, Itoh S, Goumans M, et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J, 2004，23(3)：541－551.
|
|
17 Noseda M, Chang L, McLean G, et al. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: Role of p21Cip1 repression. Mol Cell Biol, 2004，24(20)：8813－8822.
|
|
18 Sainson RC, Aoto J, Nakatsu MN, et al. Cell－autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J，2005，19(8)：1027－1029.
|
|
19 Mackenzie F, Duriez P, Wong F, et al. Notch 4 inhibits endothelial apoptosis via RBP－Jkappa－dependent and －independent pathways. J Biol Chem, 2004，279(12)：11657－11663.
|